Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer?

Disseminated micrometastatic disease limits the effectiveness of even the most aggressive locoregional treatment strategies in patients with early stage non-small cell lung cancer. One trial of the Lung Cancer Study Group (LCSG) demonstrated a significant decrease in the hazard rate for distant recu... View More